AGILENT TECHNOLOGIES, INC. (A)

Agilent Technologies, Inc. is a global life sciences, diagnostics and applied markets company, incorporated in Delaware in May 1999. It provides application-focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. In November 2024 it reorganized into a market-focused structure, and all historical segment information has been recast to match.

The company reports three segments. Life Sciences and Diagnostics Markets combines the former Diagnostics and Genomics segment with the liquid chromatography (LC) and liquid chromatography mass spectrometry (LC/MS) platforms. It covers seven areas: LC and LC/MS; cell analysis (live-cell analysis platforms, flow cytometers, plate readers); a specialty contract development and manufacturing (CDMO) business, including BIOVECTRA and nucleic acid solutions, producing oligonucleotide and other active pharmaceutical ingredients; pathology solutions for cancer diagnostics; companion diagnostics; genomics (next-generation sequencing reagents, arrays); and biomolecular analysis. Agilent CrossLab spans the lab with services (repairs, maintenance, compliance support, training), consumables (GC and LC columns, sample preparation, supplies), software and informatics (including the OpenLab suite) and laboratory automation. Applied Markets covers gas chromatography, GC/MS, spectroscopy, vacuum and remarketed instruments, with instruments and software that identify, quantify and analyze the properties of substances and products.

Customers span pharmaceutical and biopharmaceutical companies, diagnostics and clinical laboratories (hospitals, reference labs, molecular diagnostic companies), academic and government institutions, chemicals and advanced materials, food, and environmental and forensics. Environmental and forensics customers include government agencies, utilities, testing labs and law enforcement. The Life Sciences and Diagnostics Markets segment had about 22,200 customers in fiscal 2025.

Agilent sells primarily through direct sales, and also uses distributors, resellers, manufacturers' representatives and electronic commerce. A centralized order fulfillment and supply chain organization provides manufacturing, engineering and strategic sourcing, supported by shared global infrastructure services. Third parties are used selectively for some manufacturing, warehousing and logistics processes. Research and development and manufacturing sites are in California, Colorado, Delaware, Massachusetts, Texas and Vermont in the U.S., and in Australia, Canada, China, Denmark, Germany, Italy, Japan, Malaysia, Singapore and the United Kingdom. Some products are subject to FDA and other regulatory oversight. Principal competitors in Life Sciences and Diagnostics Markets include Thermo Fisher Scientific, Waters, Bruker, Shimadzu, Roche Ventana, Leica Biosystems and Twist Bioscience. The company employed about 18,100 people as of October 31, 2025.